Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03246243 · ClinicalTrials.gov registry record
Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk
A clinical trial, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- 16
- Enrollment target
NCT03246243: Clinical Trial study, sponsored by Boston Children's Hospital.
NCT03246243 is a clinical trial that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03246243 was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The main goal of this study is to quantitatively assess the sucking and feeding activity of infants at high risk of neurological impairment (preterm infants and term infants at risk of abnormal neurodevelopment) during oral sucking and feeding and correlate it with their underlying neurological impairment for the early diagnosis of brain injury.
Primary Outcome
Primary outcome will be an assessment of the sucking activity of infants with brain injury and infants without brain injury, using an FDA-approved device for sucking assessment.
Interventions
- DEVICE nfant feeding solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2021-05-18 |
Why NCT03246243 stopped before completion
NCT03246243 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which nfant feeding solution is the first listed.
NCT03246243 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03246243 about?
NCT03246243 is a clinical study titled "Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk". The main goal of this study is to quantitatively assess the sucking and feeding activity of infants at high risk of neurological impairment (preterm infants and term infants at risk of abnormal neurodevelopment) during oral sucking and feeding and correlate it with their underlying neurological impa...
What is the current status of trial NCT03246243?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2017-03-29. Estimated completion is 2021-05-18.
What interventions are being tested in trial NCT03246243?
The interventions under investigation include: nfant feeding solution (DEVICE).
Who is sponsoring clinical trial NCT03246243?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI